Damora Therapeutics, Inc. (DMRA)
Market Closed
27 Jul, 20:00
NASDAQ (NMS) NASDAQ (CM) Primary NASDAQ (NMS) $
29. 44
+0.62
+2.1513%
$
- Market Cap
- P/E Ratio
- Div Yield
537,037 Volume
- Eps
$ 28.82
Previous Close Want to track DMRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Damora Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 40 | $1,036 | $1,354.8 | $318.8 | 30.77% |
 Point72 Asset Management LP Point72 Asset Management LP | 1.19M | $30.6M | $39.38M | $8.78M | 28.69% |
 Rekah Franca Catalyst Funds Management Pty Ltd. | 17,293 | $447,889 | $591,247.67 | $143,358.67 | 32.01% |
| KJ Ken Joseph Braidwel LLP | 894,846 | $23.18M | $29.91M | $6.73M | 29.06% |
 Ilko Menkov Vestal Point Capita LLP | 600,000 | $15.54M | $20.3M | $4.76M | 30.62% |
 Raymond Debbane Siren, L.L.C. | 900,000 | $23.31M | $30.56M | $7.25M | 31.08% |
 Yuen Man Lee Persistent Asset Partners Ltd. | 5,338 | $138,254 | $165,317.86 | $27,063.86 | 19.58% |
